openPR Logo
Press release

Cystic Fibrosis Leadership Council Announces Fundraiser

08-05-2010 11:37 AM CET | Health & Medicine

Press release from: Articulon

RALEIGH, N.C. (August 4, 2010) ―The Leadership Council of the YPLC announces today that it is hosting the second annual A Night at the Theatre, Starring Grapes & Hops. The charity event (cff. org/Chapters/carolinas) will be held October 6, 2010 inside the Meymandi Theatre at the Murphey School in Raleigh. Proceeds will benefit the North Carolina chapter of the Cystic Fibrosis Foundation. Festivities will begin at 6:00 p.m.

The beer and wine tasting event is a casual and entertaining evening. Guests will have the opportunity to sample a variety of wines and locally brewed beer, expertly paired with great cuisine. The night is highlighted by live entertainment and the chance to bid on an array of auction items.

“The event is sure to be an exciting and lively evening for all,” says Kay James, executive director of the North Carolina chapter of the Cystic Fibrosis Foundation. “We are truly thankful for the diverse and talented pool of individuals that have come together to present this event.”

The Leadership Council of the YLPC includes:

Catrina Brehm, Sheraton
Matthew Cotter, Pfizer
Erick Hawkins, Rex Healthcare
Andrea Mospan, Inspire Pharmaceuticals
Cindy Stranad, Articulon
Bill Thelin, Parion Pharmaceuticals
Dave Volpe, Wells Fargo Advisors
Brad Saunders, Trio Clinical Research

Tickets for A Night at the Theatre are $60 in advance and $75 at the door. Contact: Anna Norton at or or visit

# # #

About Cystic Fibrosis Foundation:
The mission of the Cystic Fibrosis Foundation, a nonprofit donor-supported organization, is to assure the development of the means to cure and control cystic fibrosis and to improve the quality of life for those with the disease. The foundation is the leading organization in the United States devoted to cystic fibrosis. It funds and accredits the three CF care centers in North Carolina (Duke, UNC and Wake Forest) along with the other 115 CF care centers, 95 adult care programs and 50 affiliate programs, and has 80 chapters and branch offices nationwide. The Cystic Fibrosis Foundation is one of the most efficient and efficient organizations of its kind. In 2009, it received its second four-star rating for sound fiscal management from Charity Navigator, the largest independent charity evaluator in the United States. The foundation's business model has been recognized by the National Institutes of Health and by publications such as The New York Times and The Wall Street Journal.

2841 Plaza Place, Raleigh, NC‎ 27612

Media Contacts:
Cindy Stranad

Kay James

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystic Fibrosis Leadership Council Announces Fundraiser here

News-ID: 140490 • Views:

More Releases from Articulon

Regenerative Medicine Roundtable Slated for October 6
RTP, N.C. (August 25, 2010)—Nagoya University announces today it is presenting the NU Tech Regenerative Medicine Roundtable ( on October 6, 2011. The event will be held from 8 a.m. to 1:30 p.m. in the Hamner Conference Center auditorium at the North Carolina Biotechnology Center. More than 100 researchers, scientists, executives, entrepreneurs and investors are expected to attend. Six professors from the Wake Forest Institute of Regenerative Medicine, the University
Articulon Selected as Agency of Record for St. Patty’s Run Green 8K
RALEIGH, N.C. (March 2, 2011) ― Brand communication and public relations firm Articulon ( has been selected as communication agency of record for the 2011 St. Patty’s Run Green 8K ( for a third consecutive year. The event will take place on Saturday, March 5, 2011 in downtown Raleigh’s Moore Square. A portion of the proceeds will benefit the National Multiple Sclerosis Society. Articulon will continue to build brand awareness of
Brady Adds to Geothermal Team
Brady Adds to Geothermal Team
RALEIGH, N.C. (November 23, 2010) — Brady (, a company that provides energy systems and comprehensive building solutions for commercial and industrial facilities across North Carolina, announces today Tony Dillon has earned certification from the International Ground Source Heat Pump Association. “The efficiency and utility savings realized by the use of geothermal technology has made this a desirable solution for the operation of commercial buildings,” says Randy Katz, Raleigh general
CASL Leader Charlie Slagle Challenges Participants to One-Mile Race
RALEIGH, N.C. (September 2, 2010) — For a second consecutive year, Charlie Slagle, CEO of the Capital Area Soccer League (, is challenging CASL players, coaches and families to “Beat the Old Man” during the fifth annual Magnificent Mile Race ( The fundraising event will be held on September 19 in downtown Raleigh. The top five male and female CASL members who beat Slagle’s time will receive prizes and recognition

All 5 Releases

More Releases for Cystic

Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features. Get FREE PDF sample of the Report @ Top Company Profile Analysis in this Report- Cystic Fibrosis
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the
Cystic Fibrosis Therapeutics Market - Forecasts to 2026
As per the research conducted by GME, the Global Cystic Fibrosis Therapeutics Market will grow with a CAGR value of 13.5% by 2026. Cystic fibrosis is becoming more prevalent, resulting in increased awareness, technological improvements, strong pipeline prospects, and expanding R&D initiatives which are some of the factors to influence the growth of the market. The disease has no permanent cure but the symptoms and complications can be reduced by
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports. Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis". Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs